A phase II study of pazopanib as front-line therapy in patients with non-resectable or metastatic soft-tissue sarcomas who are not candidates for chemotherapy

Angela C. Hirbe, Vanessa Eulo, Chang I. Moon, Jingqin Luo, Stephanie Myles, Mahesh Seetharam, Jacqui Toeniskoetter, Tammy Kershner, Sasha Haarberg, Mark Agulnik, Varun Monga, Mohammad Milhem, Amanda Parkes, Steven Robinson, Scott Okuno, Steven Attia, Brian A. Van Tine

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II study of pazopanib as front-line therapy in patients with non-resectable or metastatic soft-tissue sarcomas who are not candidates for chemotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences